… of IgA, IgM and IgG antibodies, and we explore their roles in neutralising SARS-CoV-2, their
… Furthermore, we also review the applications of neutralising antibodies in the clinical setting…

… This approach will result in lower neutralising antibody titres. Our data suggest that lower
neutralising antibody titres might be problematic in the context of newly emerging SARS-CoV-2 …

… of protective immunity and longevity of neutralising antibodies for SARS-CoV-2. We aimed
to investigate the peak levels and dynamics of neutralising antibody waning and IgG avidity …

… infections have detectable neutralising antibodies. In this … former SARS-CoV-2 infections
who develop neutralising antibodies, … with SARS-CoV-2 infection have detectable neutralising …

… vitro neutralisation and clinical protection to understand the loss of neutralisation to existing
SARS-CoV… relating in-vitro neutralisation to protection (parameterised on data from ancestral …

… , this raises the theoretical possibility of virus escape, particularly in immunocompromised …
Here we report chronic SARS-CoV-2 with reduced sensitivity to neutralising antibodies in an …

… enable antibody evasion. Here we isolated an infectious Omicron virus in Belgium from a
traveller returning from Egypt. We examined its sensitivity to nine monoclonal antibodies that …

… detectable neutralising antibodies in response to SARS-CoV-2 … However, neutralising antibody
titres were low in a … 19) generated an antibody response capable of neutralising 42–99% …

… a small (1·7-fold) but significant increase in resistance to serum neutralisation compared
with XBB.1.16, which is known to have an antibody neutralisation profile similar to XBB.1.5. …

… clinical cohort, virus culture conditions, genetic sequencing, and neutralisation assays, and
… Using a high-throughput live-virus SARS-CoV-2 neutralisation assay (performance data are …